Persistent organic pollutants and hyperuricemia in the U.S. general population

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 1-5

  Lee, Yu Mi ^a   Bae, Sang Geun ^a   Lee, Seon Hwa ^a   Jacobs, David R ^b   Lee, Duk Hee ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dioxin; Hyperuricemia; Organochlorine pesticides; Persistent organic pollutants; Polychlorinated biphenyls

Indexed keywords

ORGANIC COMPOUND; ORGANOCHLORINE DERIVATIVE; PERSISTENT ORGANIC POLLUTANT; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; UNITED STATES;

CDC; CENTERS FOR DISEASE CONTROL AND PREVENTION; DIOXIN; HYPERURICEMIA; LIMIT OF DETECTION; LOD; METABOLIC SYNDROME; METS; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; NHANES; OC PESTICIDES; ODDS RATIOS; ORGANOCHLORINE PESTICIDES; ORS; PCBS; PCDDS; PCDFS; PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED BIPHENYLS; POLYCHLORINATED DIBENZO-P-DIOXINS; POLYCHLORINATED DIBENZOFURANS; POPS; TEFS; TOXIC EQUIVALENCY FACTORS; UA; URIC ACID;

ADULT; AGED; AGED, 80 AND OVER; BENZOFURANS; CHLORINE; CROSS-SECTIONAL STUDIES; DIOXINS; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; HYPERURICEMIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; ORGANIC CHEMICALS; PESTICIDES; POLYCHLORINATED BIPHENYLS; RISK FACTORS; TETRACHLORODIBENZODIOXIN; UNITED STATES; YOUNG ADULT;

EID: 84881657550     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.06.012     Document Type: Article

References (33)

1. Neogi T. Asymptomatic hyperuricemia: perhaps not so benign?. JRheumatol 2008, 35:734-737.
2. Conen D., Wietlisbach V., Bovet P., Shamlaye C., Riesen W., Paccaud F., et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004, 4:9.
3. Abbott R.D., Brand F.N., Kannel W.B., Castelli W.P. Gout and coronary heart disease: the Framingham Study. JClin Epidemiol 1988, 41:237-242.
4. Krishnan E., Svendsen K., Neaton J.D., Grandits G., Kuller L.H. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008, 168:1104-1110.
5. Niskanen L.K., Laaksonen D.E., Nyyssonen K., Alfthan G., Lakka H.M., Lakka T.A., et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004, 164:1546-1551.
6. Vannorsdall T.D., Jinnah H.A., Gordon B., Kraut M., Schretlen D.J. Cerebral ischemia mediates the effect of serum uric acid on cognitive function. Stroke 2008, 39:3418-3420.
7. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007, 120:442-447.
8. Tsouli S.G., Liberopoulos E.N., Mikhailidis D.P., Athyros V.G., Elisaf M.S. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?. Metabolism 2006, 55:1293-1301.
9. Facchini F., Chen Y.D., Hollenbeck C.B., Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAm Med Assoc 1991, 266:3008-3011.
10. Quinones Galvan A., Natali A., Baldi S., Frascerra S., Sanna G., Ciociaro D., et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995, 268:E1-E5.
11. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. NEngl J Med 2008, 359:1811-1821.
12. Johnson R.J., Kang D.H., Feig D., Kivlighn S., Kanellis J., Watanabe S., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003, 41:1183-1190.
13. Nakagawa T., Hu H., Zharikov S., Tuttle K.R., Short R.A., Glushakova O., et al. Acausal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Ren Physiol 2006, 290:F625-F631.
14. Ha M.H., Lee D.H., Son H.K., Park S.K., Jacobs D.R. Association between serum concentrations of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from the National Health and Nutrition Examination Survey 1999-2002. JHum Hypertens 2009, 23:274-286.
15. Lee D.H., Lee I.K., Porta M., Steffes M., Jacobs D.R. Relationship between serum concentrations of persistent organic pollutants and the prevalence of metabolic syndrome among non-diabetic adults: results from the National Healthand Nutrition Examination Survey 1999-2002. Diabetologia 2007, 50:1841-1851.
16. Lee D.H., Lee I.K., Song K., Steffes M., Toscano W., Baker B.A., et al. Astrong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diabetes Care 2006, 29:1638-1644.
17. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One 2011, 6:e15977.
18. Lee D.H., Steffes M.W., Sjodin A., Jones R.S., Needham L.L., Jacobs D.R. Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect 2010, 118:1235-1242.
19. Imamura T., Matsumoto S., Akahane M., Kanagawa Y., Koike S., Tajima B., et al. Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2,3,4,7,8-penta-chlorodibenzofurans in Yusho patients, using data mining analysis. BMC Res Notes 2009, 2:27.
20. Burgin D.E., Diliberto J.J., Derr-Yellin E.C., Kannan N., Kodavanti P.R., Birnbaum L.S. Differential effects of two lots of aroclor 1254 on enzyme induction, thyroid hormones, and oxidative stress. Environ Health Perspect 2001, 109:1163-1168.
21. Kutlu S., Colakoglu N., Halifeoglu I., Sandal S., Seyran A.D., Aydin M., et al. Comparative evaluation of hepatotoxic and nephrotoxic effects of aroclors 1221 and 1254 in female rats. Cell Biochem Funct 2007, 25:167-172.
22. Van den Berg M., Birnbaum L.S., Denison M., De Vito M., Farland W., Feeley M., et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol Sci 2006, 93:223-241.
23. Korn E.L., Graubard B.I. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991, 81:1166-1173.
24. Graubard B.I., Korn E.L. Analyzing health surveys for cancer-related objectives. JNatl Cancer Inst 1999, 91:1005-1016.
25. Choi J.W., Ford E.S., Gao X., Choi H.K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008, 59:109-116.
26. Sonne C., Bustnes J.O., Herzke D., Jaspers V.L., Covaci A., Halley D.J., et al. Relationships between organohalogen contaminants and blood plasma clinical-chemical parameters in chicks of three raptor species from Northern Norway. Ecotoxicol Environ Saf 2010, 73:7-17.
27. Tsunoda S., Kamide K., Minami J., Kawano Y. Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. Am J Hypertens 2002, 15:697-701.
28. Goncalves J.P., Oliveira A., Severo M., Santos A.C., Lopes C. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012, 41:450-457.
29. Ryu S., Song J., Choi B.Y., Lee S.J., Kim W.S., Chang Y., et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 2007, 17:245-252
30. Ryu S, Chang Y, Zhang Y, Kim SG, Cho J, Son HJ, etal., A cohort study of hyperuricemia in middle-aged South Korean men, Am J Epidemiol;175:133-143.
31. Nakagawa T., Tuttle K.R., Short R.A., Johnson R.J. Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nat Clin Pract Nephrol 2005, 1:80-86.
32. Ibrahim M.M., Fjaere E., Lock E.J., Naville D., Amlund H., Meugnier E., et al. Chronic consumption of farmed salmon containing persistent organic pollutants causes insulin resistance and obesity in mice. PLoS One 2011, 6:e25170.
33. Ruzzin J., Petersen R., Meugnier E., Madsen L., Lock E.J., Lillefosse H., et al. Persistent organic pollutant exposure leads to insulin resistance syndrome. Environ Health Perspect 2010, 118:465-471.